The Emory Chemistry-Biology Center is dedicated to working within the framework of the MLSCN to develop, at a minimum, the capacity to identify and provide ten probes for novel targets by the end of year one, and 20 probes annually by the end of year three. The Center is specifically designed to operate as a synergistic MLSCN component to facilitate: a) the discovery of small molecule tools for basic research, therapeutic development and diagnostic assays; b) annotation of chemical libraries for their biological activities; and c) organization of data for ease of public sharing and analysis. While we have the capability to adapt and optimize all target-based and phenotypic assays selected by the MLSCN, we have identified protein-protein interactions for small molecule discovery as our Center's theme. This is an area likely to impact a broad range of biological regulatory systems with significant potential for future drug discovery. We currently have a fully operational HTS Center and 100,000 compound small molecule diversity library. The Center's chemical synthesis group approaches probe discovery with a molecular optimization strategy that is efficient and adds value at every step. The Chemical and Bioinformatics team will integrate HTS, compound registration and tracking, virtual screening, chemical synthesis, data analysis, and communication with PubChem and the other MLSCN centers. The locally generated assay data will be formatted to link it with molecular structure to enable a) querying structures and data across the entire range of assays; and b) structure-activity relationships. Coordination of the Center's activities will be closely monitored by the Administrative Function, with the goal of creating an environment that speeds the discovery process for useful molecular reagents and tools targeted to proteins of unusual biommedical interest. The Center's proposed intellectual property plan is designed to incentivize investigators to submit high-quality assays to MLSCN and to maximize the impact of the MLSCN strategy on health.

Agency
National Institute of Health (NIH)
Institute
National Human Genome Research Institute (NHGRI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
1U54HG003918-01
Application #
7152310
Study Section
Special Emphasis Panel (ZMH1-ERB-Y (02))
Project Start
2005-07-01
Project End
2008-06-30
Budget Start
2005-07-01
Budget End
2006-06-30
Support Year
1
Fiscal Year
2005
Total Cost
$2,029,935
Indirect Cost
Name
Emory University
Department
Type
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Du, Yuhong; Fu, Robert W; Lou, Bin et al. (2013) A time-resolved fluorescence resonance energy transfer assay for high-throughput screening of 14-3-3 protein-protein interaction inhibitors. Assay Drug Dev Technol 11:367-81
Ndungu, J Maina; Krumm, Stefanie A; Yan, Dan et al. (2012) Non-nucleoside inhibitors of the measles virus RNA-dependent RNA polymerase: synthesis, structure-activity relationships, and pharmacokinetics. J Med Chem 55:4220-30
Olivera, Anlys; Moore, Terry W; Hu, Fang et al. (2012) Inhibition of the NF-?B signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties. Int Immunopharmacol 12:368-77
Cencic, Regina; Desforges, Marc; Hall, David R et al. (2011) Blocking eIF4E-eIF4G interaction as a strategy to impair coronavirus replication. J Virol 85:6381-9
Sun, Aiming; Moore, Terry W; Gunther, Jillian R et al. (2011) Discovering small-molecule estrogen receptor */coactivator binding inhibitors: high-throughput screening, ligand development, and models for enhanced potency. ChemMedChem 6:654-66
Du, Yuhong; Nikolovska-Coleska, Zaneta; Qui, Min et al. (2011) A dual-readout F2 assay that combines fluorescence resonance energy transfer and fluorescence polarization for monitoring bimolecular interactions. Assay Drug Dev Technol 9:382-93
Sun, Aiming; Ndungu, J Maina; Krumm, Stefanie A et al. (2011) Host-directed Inhibitors of Myxoviruses: Synthesis and in vitro Biochemical Evaluation. ACS Med Chem Lett 2:798-803
Chang, Yanqi; Ganesh, Thota; Horton, John R et al. (2010) Adding a lysine mimic in the design of potent inhibitors of histone lysine methyltransferases. J Mol Biol 400:1-7
Hansen, Kasper B; Mullasseril, Praseeda; Dawit, Sara et al. (2010) Implementation of a fluorescence-based screening assay identifies histamine H3 receptor antagonists clobenpropit and iodophenpropit as subunit-selective N-methyl-D-aspartate receptor antagonists. J Pharmacol Exp Ther 333:650-62
Jiang, Jianxiong; Ganesh, Thota; Du, Yuhong et al. (2010) Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptor. Proc Natl Acad Sci U S A 107:2307-12

Showing the most recent 10 out of 24 publications